Skip to main content
. 2011 Dec;164(7):1847–1856. doi: 10.1111/j.1476-5381.2011.01495.x

Table 2.

Effect of PF-04418948 on the butaprost IC50 value for inhibition of EFS-induced contraction of human myometrium

Butaprost IC50 value (nM)
Control 27.8 (95% CI 9.1–85, n = 5)
10 nM PF-04418948 74 (n = 1)
54 (n = 2)
100 nM PF-04418948 353 (95% CI 78–1594, n = 4)